SCHEMBL305540

SCHEMBL305540

Cc1ccc(OC(C)C2CN(C)CCN2)c(NC(=O)Nc2cnc(C#N)cn2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 20/20 0.52
▸ AURKA O14965 2/20 0.49
▸ CHEK2 O96017 1/20 0.49
▸ MARK3 P27448 1/20 0.49
▸ PRKCD Q05655 1/20 0.49
▸ RPS6KA3 P51812 2/20 0.47
▸ SRPK1 Q96SB4 2/20 0.47
▸ IKBKB O14920 1/20 0.47
▸ DCLK1 O15075 1/20 0.47
▸ RPS6KA5 O75582 1/20 0.47
▸ PRKD3 O94806 1/20 0.47
▸ MAP4K4 O95819 1/20 0.47
▸ RET P07949 1/20 0.47
▸ PHKG2 P15735 1/20 0.47
▸ CDK2 P24941 1/20 0.47
▸ FLT4 P35916 1/20 0.47
▸ MAPKAPK2 P49137 1/20 0.47
▸ CLK2 P49760 1/20 0.47
▸ GSK3B P49841 1/20 0.47
▸ IRAK1 P51617 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL305538 0.90 KDM4E (0.42) CHEK1AURKACHEK2MARK3PRKCD
SCHEMBL305539 0.78 CHEK1 (0.56) CHEK1AURKACHEK2RPS6KA3SRPK1
SCHEMBL304825 0.77 CHEK1 (0.54) CHEK1AURKACHEK2RPS6KA3SRPK1
SCHEMBL305621 0.77 CHEK1 (0.54) CHEK1AURKACHEK2RPS6KA3SRPK1
SCHEMBL2035842 0.77 KDM4E (0.45) CHEK1AURKACHEK2MARK3PRKCD
SCHEMBL305454 0.76 CHEK1 (0.46) CHEK1AURKACHEK2MARK3PRKCD
SCHEMBL2030233 0.76 KDM4E (0.44) CHEK1AURKACHEK2MARK3PRKCD
SCHEMBL2032648 0.75 CHEK1 (0.78) CHEK1AURKARPS6KA3SRPK1IKBKB
SCHEMBL2034857 0.72 KDM4E (0.47) CHEK1AURKACHEK2MARK3PRKCD
SCHEMBL305570 0.71 CHEK1 (0.63) CHEK1AURKACHEK2RPS6KA3SRPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093244-B2 Heteroaryl urea derivatives useful for inhibiting CHK1 ICOS CORPORATION (US) 2012-01-10 — — US disclosed
EP-2330105-A1 Heteroaryl urea derivatives useful for inhibiting CHK1 ICOS Corporation (US) 2011-06-08 — — EP disclosed
US-20090143357-A1 HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHK1 ICOS CORPORATION (US) 2009-06-04 — — US disclosed
EP-1869020-A1 HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHKl ICOS Corporation (US) 2007-12-26 — — EP disclosed
WO-2006105262-A1 HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHKl ICOS CORPORATION (US) 2006-10-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143357-A1 HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHK1 CHEK1, CHEK2, PCNA CHEK1 1/4885AURKA 309/4885CHEK2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback